Academic Journal
Q1International Journal of Gynecological Pathology
About International Journal of Gynecological Pathology
About International Journal of Gynecological Pathology
International Journal of Gynecological Pathology is a peer-reviewed scholarly journal published by Lippincott Williams and Wilkins (United States). It focuses on Q1. Publication coverage spans 1982-2026.
Key indicators: ISSN 1538-7151, 0277-1691; H-index 91.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (91): Strong citation impact — 91 articles cited at least 91 times each, reflecting solid influence.
Publishing in International Journal of Gynecological Pathology
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of International Journal of Gynecological Pathology?
1538-7151, 0277-1691.
Who publishes International Journal of Gynecological Pathology?
Lippincott Williams and Wilkins.
What are International Journal of Gynecological Pathology's metrics?
H-index 91.
Is International Journal of Gynecological Pathology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Ovarian cancer diagnosis and treatment; Endometrial and Cervical Cancer Treatments; Uterine Myomas and Treatments; Cervical Cancer and HPV Research; Sarcoma Diagnosis and Treatment; Endometriosis Research and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Vulvovaginal Myxoid Epithelioid Smooth Muscle Tumor With NCOA2 Rearrangement: Case Report and Literature Review
Lingxuan Li, Ying Shao, Xiaofei Zhang, Bingjian Lu et al.
2026-10-12 · DOI: 10.1097/pgp.0000000000001221Primary Vulvar HPV-independent Adenosquamous Carcinoma: A Case Series of a Rare Neoplasm With an Apparent Predilection for the Upper Vulva
Lisa Vermij, Tjalling Bosse, Maysa Al-Hussaini, W. Glenn McCluggage et al.
2026-09-28 · DOI: 10.1097/pgp.0000000000001206Interobserver Variability in Diagnosing STIC With Frequent Underdiagnosis of Early High-grade Serous Carcinoma: Insights From a Multicenter Review From the CANSTIC Study
Sarah E.J. Khan, Martin Köbel, Elisabeth Spénard, Lien Hoang et al.
2026-09-28 · DOI: 10.1097/pgp.0000000000001218Diagnostically Confusing Aspects of the Physiologic Ovarian Follicle: A Report of 57 Cases and Brief Review of Selected Other Non-neoplastic Ovarian Lesions
Negar Taheri, Robert H. Young, Esther Oliva, Kyle M. Devins et al.
2026-09-28 · DOI: 10.1097/pgp.0000000000001217Repurposing Gastric Cancer Biomarkers for Mucinous Ovarian Carcinoma: ERBB2 and Claudin 18.2 as Therapeutic Targets
Shuaijin Wang, Astrid De Boeck, Eun Young Kang, Nicola S. Meagher et al.
2026-09-28 · DOI: 10.1097/pgp.0000000000001219Unusual Variants of Endometrial Stromal Sarcoma
Amr Abulaban, Andre Pinto
2026-09-21 · DOI: 10.1097/pgp.0000000000001216Poor Prognosis and High Recurrence in NTRK3 Fusion Cervical Sarcoma: A Series of 3 Cases and Literature Review
Wan Xiong, Junbo Hu, Zhigan Wang, Fang Yu et al.
2026-09-16 · DOI: 10.1097/pgp.0000000000001215Uterine Carcinosarcoma: Mutational Profiling of p53-Abnormal Tumors and Its Association with Histologic Subtypes and Survival in an Underserved Population
Jing Zhou, Marianne E. Yassa, Delaney Yu, Hector Chavarria Bernal et al.
2026-09-14 · DOI: 10.1097/pgp.0000000000001214POLD1 and Endometrial Cancer: Molecular Mechanisms, Genomic Pathology, and Emerging Therapeutics
Anas Houlal, Mousa Mobarki, Shaqraa Musawi, Michel Péoc’h et al.
2026-09-02 · DOI: 10.1097/pgp.0000000000001211Novel Gene Fusions and Pathogenic CTNNB1 Mutation in Pilomatrix-like High-grade Endometrioid Carcinoma: Expanding the Molecular Spectrum
Dorukhan Gül, Ahmet Erbağci, Furkan Aknar, İlker Nihat Ökten et al.
2026-08-31 · DOI: 10.1097/pgp.0000000000001212Folate Receptor Alpha (FRα/FOLR1) Immunohistochemical Expression Across Molecularly Classified Endometrial Carcinomas
Diane Libert, Brooke Liang, Sabrina Zdravkovic, Austin McHenry et al.
2026-11 · DOI: 10.1097/pgp.0000000000001208Uterine Tumor With Myogenic Differentiation and SRF::RELA Fusion Manifesting as Endometrial Polyp
Monika Manethová, Jan Hojný, Pavel Dundr
2026-08-05 · DOI: 10.1097/pgp.0000000000001209Folate Receptor Immunohistochemical Staining Heterogeneity in Gynecologic Cancers
Barrett C. Lawson, Anais Malpica
2026-08-04 · DOI: 10.1097/pgp.0000000000001210SOX2 Can Support a Diagnosis of PiMHEC With Rare to Absent Ghost Cells and Can Distinguish PiMHEC From Its Most Problematic Mimickers
Jin Xu, Paul S. Weisman
2026-11 · DOI: 10.1097/pgp.0000000000001197PAX8-Negative HPV-Associated Endocervical Adenocarcinoma With a Micropapillary Component: A Diagnostic Pitfall Mimicking Metastatic Carcinoma
Furkan Aknar, Sevil Albayrak, Dorukhan Gül, İlker Nihat Ökten et al.
2026-11 · DOI: 10.1097/pgp.0000000000001207An Endometrioid Carcinoma With an Adenoma Malignum-like Pattern of Invasion: New Insight into Molecular Features
Meng Jia, Shi-Li Yu, Ping-Li Sun
2026-07-15 · DOI: 10.1097/pgp.0000000000001205Endometrial Mesonephric-like Carcinosarcoma With Shared KRAS, TP53, and RB1 Mutations: Report of a Rare Case Highlighting Diagnostic Challenges and Novel Molecular Insights, and Review of the Literature
Zitong Zhao, Timothy Kwang Yong Tay, Tony Kiat Hon Lim, Liang Seah Tay et al.
2026-07-03 · DOI: 10.1097/pgp.0000000000001203Tumor Grade in Molecularly Defined Endometrial Carcinoma: Prognostic Implications of the ESGO–ESTRO–ESP 2025 Guidelines
Mikko Loukovaara, Annukka Pasanen, Ralf Bützow
2026-07-02 · DOI: 10.1097/pgp.0000000000001202Bilateral Ovarian Anastomosing Hemangioma Mimicking Malignancy: A Frozen Section Diagnostic Pitfall
Camilla Gennaioli, Nataniele Piol, Anjeza Xholli, Angelo Cagnacci et al.
2026-07-01 · DOI: 10.1097/pgp.0000000000001204Comparative Molecular Profiling of Basal Cell Carcinomas in Sun-Exposed and Anogenital Regions
Ahlam Ali, Pelin Onur, Anas Mohamed, Shamsu Bello et al.
2026-07-01 · DOI: 10.1097/pgp.0000000000001201Reviews
Community Reviews
Version History
October 9, 2026 at 9:58 pm
October 2, 2026